創科局:240萬市民已登記索口罩 晶苑(02232.HK)原本希望低調「不開名」
創新及科技局局長薛永恆指,直至今早(8日)9時已經有240萬名香港市民登記索取「銅芯抗疫口罩+」,明白市民對相關技術或有疑問,已安排香港紡織及成衣研發中心的專家稍後與大家見面,助大家了解口罩本身的技術。
針對有報道指口罩並無加入當日在記者會上提及的專利,薛永恆指專利的設計與現時的口罩是同源的,所以相關專利仍然是適合作為這款口罩的基礎。專家會向大家講解為何這個專利是可以支持這款口罩成功抗疫。對政府來說,最重要的一點是這款口罩能夠符合ASTM-F2100一級標準,這個標準其實確保得到口罩的過濾能力等,符合一般抗疫需要的水平,政府已做充分確認,請大家放心。
針對政府尋找晶苑國際(02232.HK)時並無經公開招標,會否涉內幕交易及利益衝突等,薛永恆指有能力在這麼短時間內能夠提供這個數量可重用口罩給香港市民並不容易,晶苑是其中一個協助完成這項工作的團體,在過程中公司希望比較低調,不需要開名,讓它可以專心做好自己相關的工作。有些傳媒朋友或市民都希望多點了解過程,最後公司願意讓局方提供相關資料。
他指出局方對業界朋友非常感恩,還有很多前線工友等,認為這班已退休、重出江湖的紡織工友,更加值得表揚。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.